Contrary to common belief, YC partners may review and even encourage the submission of incomplete applications after the deadline. Aegis's founders were contacted by a partner who saw potential in their draft and urged them to finish and submit it, leading to their acceptance.
Beyond tactical advice, a subtle but crucial YC teaching is the importance of being helpful to the community. The culture, reinforced by practices like "shout outs" for helpful batchmates, ingrains the idea that success is tied to being relentlessly resourceful for others, not just for oneself.
To avoid the post-YC slump, Aegis's founders maintained momentum by continuing their group office hours for accountability and setting a weekly goal to meet with one exceptional founder. This external input and accountability helps replicate the high-velocity environment of the accelerator batch.
The difference between a feature company and a potential unicorn is vision. Instead of focusing only on a solution (appealing denied claims), Aegis focuses on the bigger problem (getting hospitals paid faster). This opens up a larger roadmap, including lucrative opportunities like financing claims, which attracts venture capital.
To break into slow-moving hospitals, Aegis initially targeted smaller, more agile medical billing companies that serve them. This strategy builds a proven product and case studies with customers who have a direct need and faster sales cycles, creating a powerful entry point to the larger hospital systems.
A major market opportunity exists when one side of an industry (e.g., insurance companies) adopts new technology like AI faster than its counterpart (e.g., hospitals). Startups can succeed by building tools that close this technology gap, effectively 'arming the rebels' and leveling the playing field.
In industries with long sales cycles like healthcare, early traction isn't about dozens of logos. For YC's Demo Day, Aegis focused on securing just one large medical billing company as a happy, paying customer. Deep engagement—evidenced by data sharing and product co-development—is a powerful early signal for investors.